Intravenous esomeprazole (Nexium) is approved in Europe for the prevention of rebleeding following therapeutic … high-risk stigmata who received intravenous esomeprazole for 72 hours following endoscopic haemostatic therapy were … additional hospital days required because of rebleeding were significantly lower in intravenous esomeprazole recipients than in …

00251979) showed that high-dose intravenous (IV) esomeprazole, when administered after successful endoscopic haemostasis in …. Objective: Using a decision-tree model, we compared the cost efficacy of high-dose IV esomeprazole versus an approach of no … successful endoscopic haemostasis, patients received either high-dose IV esomeprazole (80 mg infusion over 30 min, then 8 mg …

Aim: To evaluate the costs and effectiveness of on-demand maintenance therapy with oral esomeprazole, lansoprazole …; _176 and 0.90 for pantoprazole 20mg; _190 and 0.89 for esomeprazole 20mg; _195 and 0.91 for lansoprazole 15mg; _201 and 0 …

Objectives: To evaluate the cost effectiveness of on-demand treatment with esomeprazole 20mg compared with two …) without oesophagitis. Design: A simple Markov model was designed to compare the cost effectiveness of on-demand esomeprazole … results from two 6-month placebo-controlled clinical studies of on-demand esomeprazole 20mg treatment in patients with GORD …

Background: Clinical studies have demonstrated that esomeprazole is superior to omeprazole for the acute treatment of … reflux oesophagitis. Objective: To compare the cost effectiveness of esomeprazole 40mg once daily with omeprazole 20mg once … efficacy and safety of esomeprazole 40mg once daily and omeprazole 20mg once daily for the acute treatment of reflux …